FDA Inspection 869236 — Amerx Health Care Corp.

Amerx Health Care Corp. — FEI 1000525408

The FDA completed an inspection of Amerx Health Care Corp. on February 24, 2014 in Clearwater, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 19 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 24, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Compliance: Devices
Location
Clearwater, FL (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1471421 CFR 820.30(c)Design input - Lack of or inadequate procedures
1471521 CFR 820.30(d)Design output - Lack of or inadequate procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
243021 CFR 820.30(b)Design plans - Lack of or inadequate
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
310221 CFR 820.30(h)Design transfer - Lack of or inadequate procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
310421 CFR 820.30(j)Design history file
313021 CFR 820.100(a)Lack of or inadequate procedures
316821 CFR 820.198(a)Complaints
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
328621 CFR 820.90(b)(1)Procedures for product review,disposition lack of/inadequate
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures
369621 CFR 820.100(b)Documentation
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
63021 CFR 803.17Lack of Written MDR Procedures